Jared Gollob
Chief Tech/Sci/R&D Officer bij KYMERA THERAPEUTICS, INC.
Vermogen: 4 M $ op 31-03-2024
Profiel
Jared Gollob is currently the Chief Medical Officer at Kymera Therapeutics, Inc. Prior to this, he was the Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Before that, he was the Director-Biologic Therapy Program at Duke University from 2002 to 2007.
Dr. Gollob received his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-03-2024 | 95 740 ( 0.16% ) | 4 M $ | 31-03-2024 |
Actieve functies van Jared Gollob
| Bedrijven | Functie | Begin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2018 |
Eerdere bekende functies van Jared Gollob
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-08-2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01-09-2007 |
Opleiding van Jared Gollob
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
